Serum YKL-40 as a Potential Diagnostic and Prognostic Biomarker in Asthma: Correlations with Exacerbation, Inflammatory Markers, and Disease Severity
(2024). Serum YKL-40 as a Potential Diagnostic and Prognostic Biomarker in Asthma: Correlations with Exacerbation, Inflammatory Markers, and Disease Severity. EKB Journal Management System, 94(1), 215-223. doi: 10.21608/ejhm.2024.335039
. "Serum YKL-40 as a Potential Diagnostic and Prognostic Biomarker in Asthma: Correlations with Exacerbation, Inflammatory Markers, and Disease Severity". EKB Journal Management System, 94, 1, 2024, 215-223. doi: 10.21608/ejhm.2024.335039
(2024). 'Serum YKL-40 as a Potential Diagnostic and Prognostic Biomarker in Asthma: Correlations with Exacerbation, Inflammatory Markers, and Disease Severity', EKB Journal Management System, 94(1), pp. 215-223. doi: 10.21608/ejhm.2024.335039
Serum YKL-40 as a Potential Diagnostic and Prognostic Biomarker in Asthma: Correlations with Exacerbation, Inflammatory Markers, and Disease Severity. EKB Journal Management System, 2024; 94(1): 215-223. doi: 10.21608/ejhm.2024.335039